Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1493 publications
Global Cancer Stem Cell Therapy Industry Market Research 2017 US$ 2,600.00

... driving the global Cancer Stem Cell Therapy industry? 8. What are the key market trends impacting the growth of the Cancer Stem Cell Therapy market? 9. What are the Cancer Stem Cell Therapy market challenges to market growth? 10. What are the Cancer Stem Cell Therapy market opportunities and threats faced by the vendors in the global Cancer Stem Cell Therapy market ...

May, 2017 147 pages
The 2018-2023 World Outlook for Liver Cancer Therapeutics US$ 995.00

This study covers the world outlook for liver cancer therapeutics across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 292 pages
The 2018-2023 World Outlook for Hematological Cancer Treatments US$ 995.00

This study covers the world outlook for hematological cancer treatments across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 294 pages
The 2018-2023 World Outlook for Colorectal Cancer Treatments US$ 995.00

This study covers the world outlook for colorectal cancer treatments across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) US$ 995.00

This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 309 pages
The 2018-2023 World Outlook for Colorectal Cancer Drugs US$ 995.00

This study covers the world outlook for colorectal cancer drugs across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer-treating Drugs US$ 995.00

This study covers the world outlook for cancer-treating drugs across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Vaccines US$ 995.00

This study covers the world outlook for cancer vaccines across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... cancer vaccines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Profiling Technologies US$ 995.00

This study covers the world outlook for cancer profiling technologies across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Pain Management US$ 995.00

This study covers the world outlook for cancer pain management across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Immunotherapies US$ 995.00

This study covers the world outlook for cancer immunotherapies across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Diagnostics US$ 995.00

This study covers the world outlook for cancer diagnostics across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer Biomarkers US$ 995.00

This study covers the world outlook for cancer biomarkers across more than 190 countries. For ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Cancer and Tumor Profiling US$ 995.00

This study covers the world outlook for cancer and tumor profiling across more than 190 ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... tumor profiling. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Breast Cancer Treatments US$ 995.00

This study covers the world outlook for breast cancer treatments across more than 190 countries. ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 293 pages
The 2018-2023 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) US$ 995.00

This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 301 pages
The 2018-2023 World Outlook for Breast Cancer Diagnostics and Drug Technologies US$ 995.00

This study covers the world outlook for breast cancer diagnostics and drug technologies across more ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ...

Apr, 2017 310 pages
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market US$ 4,995.00 US$ 3,996.00

... HER) 2-negative segment and the HER2-positive segment. HER2-positive breast cancer is aggressive and, historically, has had a worse overall survival than HER2-negative disease, which is considered less aggressive. In HER2-negative breast cancer ...

Apr, 2017 176 pages
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets US$ 4,995.00 US$ 3,996.00

... cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis ...

Mar, 2017 126 pages
Global Specific Cancer Immunotherapy Drugs Industry Market Research 2017 US$ 2,600.00

... driving the global Specific Cancer Immunotherapy Drugs industry? 8. What are the key market trends impacting the growth of the Specific Cancer Immunotherapy Drugs market? 9. What are the Specific Cancer Immunotherapy Drugs market challenges to market growth? 10. What are the Specific Cancer Immunotherapy Drugs market opportunities and threats faced by the vendors in the global Specific Cancer Immunotherapy Drugs market ...

Apr, 2017 145 pages
Global Non-Specific Cancer Immunotherapy Drug Industry Market Research 2017 US$ 2,600.00

... driving the global Non-Specific Cancer Immunotherapy Drug industry? 8. What are the key market trends impacting the growth of the Non-Specific Cancer Immunotherapy Drug market? 9. What are the Non-Specific Cancer Immunotherapy Drug market challenges to market growth? 10. What are the Non-Specific Cancer Immunotherapy Drug market opportunities and threats faced by the vendors in the global Non-Specific Cancer Immunotherapy Drug market ...

Apr, 2017 156 pages
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 US$ 2,400.00

... cancer vaccine, 44 Cancer monoclonal antibodies, 3 cancer cell therapies and 61 cancer Immunomodulators are commercially available in the market. Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies ...

Apr, 2017 280 pages
Global Cancer Diagnostic Devices Industry Market Research 2017 US$ 2,600.00

... driving the global Cancer Diagnostic Devices industry? 8. What are the key market trends impacting the growth of the Cancer Diagnostic Devices market? 9. What are the Cancer Diagnostic Devices market challenges to market growth? 10. What are the Cancer Diagnostic Devices market opportunities and threats faced by the vendors in the global Cancer Diagnostic Devices market ...

Apr, 2017 163 pages
Global Breast Cancer Predictive Genetic Testing Market Outlook 2022 US$ 2,000.00

... Breast Cancer Predictive Genetic Testing Market Outlook 2022” Report Highlights: Hereditary Breast Cancer Genes Conceptual of Breast Cancer Susceptibility Predictive Cancer Testing Essentials Economical, Ethical & Social Aspects Global Prevalence of Breast Cancer Market & Cost Analysis of Predictive Testing ...

Apr, 2017 140 pages
North America Prostate Cancer Diagnostics Market by Manufacturers, Countries, Type and Application, Forecast to 2022 US$ 4,480.00

... exam, biopsy and others to diagnostic whether patients with breast cancer. SCOPE OF THE REPORT: This report focuses on the Prostate Cancer Diagnostics in North America market, especially in United ... into < 55 55-75 > 75 There are 15 Chapters to deeply display the North America Prostate Cancer Diagnostics market. Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market ...

Apr, 2017 119 pages
Global Cancer Biomarkers Market Research and Analysis 2015-2022 US$ 3,495.00

... global cancer biomarkers market. Geographical Insights Global Cancer biomarkers market can be segmented geographically into North America, Asia Pacific, Europe and RoW. In 2016, North America leads the global cancer biomarkers market ... government policies impacting the global Cancer biomarkers market Insights about market determinants which are stimulating the global Cancer biomarkers market Detailed and extensive market segments with regional distribution ...

Mar, 2017
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation US$ 6,995.00 US$ 5,596.00

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck squamous cell carcinoma is the sixth most common cancer, and its incidence is rising. The ...

Mar, 2017 78 pages
Hypopharyngeal Cancer - Pipeline Review, H1 2017 US$ 2,000.00 US$ 1,600.00

... pipeline guide Hypopharyngeal Cancer – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hypopharyngeal Cancer (Oncology), complete with analysis by stage of development ...

Mar, 2017 92 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2017 US$ 2,000.00 US$ 1,600.00

... pipeline guide Cancer Anorexia-Cachexia Syndrome – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cancer Anorexia-Cachexia Syndrome (Oncology), complete with analysis by stage of development ...

Mar, 2017 98 pages
Opportunity in Lung Cancer Therapeutics in Global Market - 2017 US$ 4,500.00

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...

Mar, 2017 50 pages
Opportunity in Liver Cancer Therapeutics in Global Market - 2017 US$ 4,500.00

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...

Mar, 2017 50 pages
Opportunity in Colorectal Cancer Therapeutics in Global Market - 2017 US$ 4,500.00

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...

Mar, 2017 50 pages
Opportunity in Cancer Supportive Care Products in Global Market - 2017 US$ 4,500.00

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...

Mar, 2017 50 pages
Opportunity in Cancer Biomarkers Market in Global Market - 2017 US$ 4,500.00

... current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details ...

Mar, 2017 50 pages
Opportunity in Breast Cancer Therapeutics in Global Market - 2017 US$ 4,500.00

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...

Mar, 2017 50 pages
Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market size of the Colorectal Cancer ...

Apr, 2017 115 pages
Oesophageal Cancer Forecast in 18 Major Markets 2017-2027 US$ 6,150.00

... tumours of the oesophagus are responsible for the majority of oesophageal cancers. The majority of oesophageal cancers can be subdivided into two main histological subtypes: Adenocarcinomas ... level across the 10-year forecast snapshot. There are several features associated with the development and progression of oesophageal cancer, these include: Fistula ...

Mar, 2017 70 pages
Colorectal Cancer Forecast in 18 Major Markets 2017-2027 US$ 6,150.00

... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Colorectal Cancer include: Change in bowel habits, including diarrhoea ... on the impact from specific co-morbid conditions on Colorectal Cancer incident population. Identify sub-populations within Colorectal Cancer which require treatment. Gain an understanding of the ...

Mar, 2017 90 pages
Companion Diagnostic Tests In Oncology - South America Analysis and Market Forecasts US$ 4,450.00 US$ 3,560.00

Companion Diagnostic Tests In Oncology - South America Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... report focuses on the companion diagnostic testing markets in South America to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face ...

Dec, 2016
Companion Diagnostic Tests in Oncology - North America Analysis and Market Forecasts US$ 4,450.00 US$ 3,560.00

Companion Diagnostic Tests in Oncology - North America Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... report focuses on the companion diagnostic testing markets in North America to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face ...

Dec, 2016
Companion Diagnostic Tests in Oncology - Current and Future Players US$ 3,500.00 US$ 2,800.00

Companion Diagnostic Tests in Oncology - Current and Future Players SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... needs in the global market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face of rapid technological advancement. The four ...

Dec, 2016
Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts US$ 4,450.00 US$ 3,560.00

Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts SUMMARY Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a ... companion diagnostic testing markets in Japan, China and India, to identify unmet needs in the APAC market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing ...

Dec, 2016
Companion Diagnostic Tests in Oncology - 5EU Analysis and Market Forecasts US$ 4,450.00 US$ 3,560.00

Companion Diagnostic Tests in Oncology - 5EU Analysis and Market Forecasts SUMMARY Companion diagnostics is ... companion diagnostic testing markets in Europe to identify unmet needs in the market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing ...

Dec, 2016
Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific,... US$ 4,950.00

The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand ... the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment Some of the major companies operating in this market ...

Feb, 2017 90 pages
United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,700.00

The United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview ... 4 company 5 company 6 company 7 company 8 company 9 United States Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III United States Cervical Cancer Vaccine Market: Application Segment Analysis Application ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Sales Market Report Forecast 2017-2021 US$ 3,800.00

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 2,800.00

The Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Global Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III Global Cervical Cancer Vaccine Market: Application ...

Feb, 2017 112 pages
Global Cervical Cancer Vaccine Market Professional Survey Report Forecast 2017-2021 US$ 3,400.00

This report studies Cervical Cancer Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and ... to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering MSD GSK ...

Feb, 2017 112 pages
Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,800.00

The Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... in the market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Europe Cervical Cancer Vaccine Market Analysis by Product: Type I Type II Type III Europe Cervical Cancer Vaccine Market Analysis ...

Feb, 2017 112 pages
China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 US$ 3,100.00

The China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 China Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III China Cervical Cancer Vaccine Market: Application ...

Feb, 2017 112 pages
1 2 3 4 5 >
Skip to top